Mary Francis Shannon

Title: Mary Francis Shannon: Innovator in Haemopoietic Growth Factor Antagonists

Introduction

Mary Francis Shannon is a notable inventor based in Crafers, Australia. She has made significant contributions to the field of biomedical research, particularly in the development of haemopoietic growth factor antagonists. Her work focuses on addressing the challenges posed by native haemopoietic growth factors in the treatment of various medical conditions.

Latest Patents

Mary Francis Shannon holds a patent for "Haemopoietic growth factor antagonists and uses therefor." This invention relates to variant recombinant forms of haemopoietic growth factors that serve as antagonists to their native counterparts. The application of her invention is crucial in ameliorating the aberrant effects caused by these native molecules, particularly in the treatment of tumors, cancers, and inflammation.

Career Highlights

Throughout her career, Mary has demonstrated a commitment to advancing medical science. She is currently associated with Breasagen Limited, where she continues to innovate and contribute to the field. Her expertise and dedication have positioned her as a key figure in her area of research.

Collaborations

Mary has collaborated with esteemed colleagues, including Angel Francisco Lopez and Stan Bastiras. These partnerships have further enriched her research and expanded the impact of her inventions.

Conclusion

Mary Francis Shannon is a pioneering inventor whose work on haemopoietic growth factor antagonists has the potential to transform treatment options for various medical conditions. Her contributions to the field are invaluable and continue to inspire future innovations.